Nordson Corporation (NDSN) Q4 2025 Earnings Call Transcript
Sales (Q4 2025) $752 million, up 1% compared to the prior year's fourth quarter sales of $744 million. Organic sales decreased 1%, with growth in the Medical segment offset by softness in Industrial and Advanced Technology systems product lines. Currency translation had a positive impact of 2%.
Adjusted Earnings Per Share (Q4 2025) $3.03, a 9% increase over the prior year. This reflects strong operational performance and improved portfolio mix due to the divestiture of the medical contract manufacturing business.
EBITDA (Q4 2025) $256 million, up 6% year-over-year, representing 34% of sales. This is a 160 basis point improvement over the prior year, driven by operational performance, portfolio mix improvement, and restructuring actions.
Cash Flow (Q4 2025) $194 million, a record with a conversion rate to net income of 128%. This enabled share repurchases, dividend payments, and debt reduction.
Sales (Fiscal Year 2025) $2.8 billion, up 4% from last year. Organic sales were down 3%, but acquisition and divestiture activity added a net 6% to sales. Currency provided a modest benefit.
Adjusted Earnings Per Share (Fiscal Year 2025) $10.24, up 5% from the prior year, exceeding the midpoint of initial full-year guidance.
Gross Margins (Fiscal Year 2025) Maintained at 55%, demonstrating value and differentiation despite an evolving tariff environment.
EBITDA (Fiscal Year 2025) $900 million, up 6%, achieving the 2025 Ascend Strategy goal. This reflects a full-year incremental EBITDA margin of 49%.
Free Cash Flow (Fiscal Year 2025) $661 million, a record with a cash conversion rate of 136% on net income. This enabled $300 million in share repurchases, $179 million in dividends, and $224 million in net debt reduction.
Industrial Precision Solutions Sales (Q4 2025) $362 million, down 2% compared to the prior year. Organic sales decreased 4%, with currency providing a 2% favorable impact. Declines in polymer processing and industrial coating systems were offset by growth in precision agriculture and packaging product lines.
Medical and Fluid Solutions Sales (Q4 2025) $220 million, up 10% compared to the prior year. Organic sales increased 7%, driven by broad-based demand. EBITDA was $88 million, or 40% of sales, up 21% year-over-year.
Advanced Technology Solutions Sales (Q4 2025) $171 million, down 4% compared to the prior year. Organic sales decreased 5%, with a small positive currency benefit. Weakness in x-ray systems demand overshadowed growth in electronic dispense product lines.
Trade with 70% Backtested Accuracy
Analyst Views on NDSN
About NDSN
About the author


- Market Performance: Equities experienced a decline last week, with all three major indexes falling by at least 1.2%.
- Economic Indicators: This downturn occurred despite a better-than-expected jobs report from the Bureau of Labor Statistics and a relatively stable inflation report.
- Earnings Release Schedule: Nordson Corporation will release its Q1 FY2026 earnings on February 18, 2026, after market close, reflecting its commitment to financial transparency and investor engagement.
- Webcast Timing: The company will host its quarterly webcast on February 19, 2026, at 8:30 AM ET, allowing investors to access the latest financial information and engage in real-time discussions.
- Replay Access: For investors unable to participate live, Nordson provides a replay link for the earnings webcast, ensuring that all stakeholders can access critical information and enhancing investor relations.
- Company Background: Founded in 1954 and headquartered in Westlake, Ohio, Nordson operates in over 35 countries, focusing on precision technology and diverse markets, showcasing its robust global operational capabilities.
- Dividend Expectation Analysis: Nordson Corp.'s recent dividend history suggests a potential continuation of a 1.4% annualized yield, reflecting the impact of profitability fluctuations on dividend payments, prompting investors to monitor earnings changes to assess future sustainability.
- Options Trading Dynamics: On Monday, the put volume among S&P 500 components reached 958,732 contracts, while call volume hit 2.08M, resulting in a put:call ratio of 0.46, indicating a preference for call options among investors, which may signal optimism regarding Nordson's stock price increase.
- Volatility Calculation: The trailing twelve-month volatility for Nordson Corp. stands at 27%, and with the current stock price at $243.48, investors can leverage this data to evaluate the risk-reward profile of selling covered calls at the $270 strike for June 2026.
- Options Market Trends: The current call option trading volume significantly exceeds the long-term median put:call ratio of 0.65, indicating a bullish market sentiment where investors are more inclined to choose call contracts, potentially influencing Nordson's stock price trajectory.
Fourth Quarter Performance: Nordson Corporation reported adjusted earnings of $3.03 per share for Q4 fiscal 2025, exceeding estimates and showing a 9% year-over-year increase, while revenues of $751.8 million fell short of expectations, rising only 1% from the previous year.
Segment Revenue Breakdown: The Medical and Fluid Solutions segment saw a 9.6% increase in revenue, while Industrial Precision Solutions and Advanced Technology Solutions experienced declines of 1.5% and 3.6%, respectively, highlighting mixed performance across different business areas.
Financial Metrics: Nordson's gross profit increased by 5.1% to $423.5 million, with a gross margin improvement of 220 basis points to 56.3%. The company also reduced selling and administrative expenses by 7% year-over-year.
Future Projections: For fiscal 2026, Nordson anticipates sales between $2.83 billion and $2.95 billion, with adjusted earnings projected at $10.80 to $11.50 per share, indicating a cautious but optimistic outlook for the upcoming year.








